Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines

The formation of two nanodelivery systems, Sorafenib (SF)-loaded chitosan (SF-CS) and their folate-coated (SF-CS-FA) nanoparticles (NPs), were developed to enhance SF drug delivery on human Hepatocellular Carcinoma (HepG2) and Colorectal Adenocarcinoma (HT29) cell lines. The ionic gelation method wa...

Full description

Bibliographic Details
Main Authors: Ruman, Umme, Buskaran, Kalaivani, Pastorin, Giorgia, Masarudin, Mas Jaffri, Fakurazi, Sharida, Hussein, Mohd Zobir
Format: Article
Published: MDPI AG 2021
_version_ 1825937541766840320
author Ruman, Umme
Buskaran, Kalaivani
Pastorin, Giorgia
Masarudin, Mas Jaffri
Fakurazi, Sharida
Hussein, Mohd Zobir
author_facet Ruman, Umme
Buskaran, Kalaivani
Pastorin, Giorgia
Masarudin, Mas Jaffri
Fakurazi, Sharida
Hussein, Mohd Zobir
author_sort Ruman, Umme
collection UPM
description The formation of two nanodelivery systems, Sorafenib (SF)-loaded chitosan (SF-CS) and their folate-coated (SF-CS-FA) nanoparticles (NPs), were developed to enhance SF drug delivery on human Hepatocellular Carcinoma (HepG2) and Colorectal Adenocarcinoma (HT29) cell lines. The ionic gelation method was adopted to synthesize the NPs. The characterizations were performed by DLS, FESEM, TEM, XRD, TGA, FTIR, and UV-visible spectroscopy. It was found that 83.7 ± 2.4% and 87.9 ± 1.1% of encapsulation efficiency; 18.2 ± 1.3% and 19.9 ± 1.4% of loading content; 76.3 ± 13.7 nm and 81.6 ± 12.9 nm of hydrodynamic size; 60–80 nm and 70–100 nm of TEM; and FESEM sizes of near-spherical shape were observed, respectively, for SF-CS and SF-CS-FA nanoparticles. The SF showed excellent release from the nanoparticles under pH 4.8 PBS solution, indicating a good delivery system for tumor cells. The cytotoxicity study revealed their better anticancer action towards HepG2 and HT29 cell lines compared to the free sorafenib. Moreover, both NPs systems showed negligible toxicity to normal Human Dermal Fibroblast adult cells (HDFa). This is towards an enhanced anticancer drug delivery system with sustained-release properties for better cancer management.
first_indexed 2024-03-06T11:01:04Z
format Article
id upm.eprints-95251
institution Universiti Putra Malaysia
last_indexed 2024-03-06T11:01:04Z
publishDate 2021
publisher MDPI AG
record_format dspace
spelling upm.eprints-952512023-01-31T04:13:23Z http://psasir.upm.edu.my/id/eprint/95251/ Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines Ruman, Umme Buskaran, Kalaivani Pastorin, Giorgia Masarudin, Mas Jaffri Fakurazi, Sharida Hussein, Mohd Zobir The formation of two nanodelivery systems, Sorafenib (SF)-loaded chitosan (SF-CS) and their folate-coated (SF-CS-FA) nanoparticles (NPs), were developed to enhance SF drug delivery on human Hepatocellular Carcinoma (HepG2) and Colorectal Adenocarcinoma (HT29) cell lines. The ionic gelation method was adopted to synthesize the NPs. The characterizations were performed by DLS, FESEM, TEM, XRD, TGA, FTIR, and UV-visible spectroscopy. It was found that 83.7 ± 2.4% and 87.9 ± 1.1% of encapsulation efficiency; 18.2 ± 1.3% and 19.9 ± 1.4% of loading content; 76.3 ± 13.7 nm and 81.6 ± 12.9 nm of hydrodynamic size; 60–80 nm and 70–100 nm of TEM; and FESEM sizes of near-spherical shape were observed, respectively, for SF-CS and SF-CS-FA nanoparticles. The SF showed excellent release from the nanoparticles under pH 4.8 PBS solution, indicating a good delivery system for tumor cells. The cytotoxicity study revealed their better anticancer action towards HepG2 and HT29 cell lines compared to the free sorafenib. Moreover, both NPs systems showed negligible toxicity to normal Human Dermal Fibroblast adult cells (HDFa). This is towards an enhanced anticancer drug delivery system with sustained-release properties for better cancer management. MDPI AG 2021-02-16 Article PeerReviewed Ruman, Umme and Buskaran, Kalaivani and Pastorin, Giorgia and Masarudin, Mas Jaffri and Fakurazi, Sharida and Hussein, Mohd Zobir (2021) Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines. Nanomaterials, 11 (2). pp. 1-26. ISSN 1758-1745; ESSN: 2079-4991 https://www.mdpi.com/2079-4991/11/2/497/htm 10.3390/nano11020497
spellingShingle Ruman, Umme
Buskaran, Kalaivani
Pastorin, Giorgia
Masarudin, Mas Jaffri
Fakurazi, Sharida
Hussein, Mohd Zobir
Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines
title Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines
title_full Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines
title_fullStr Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines
title_full_unstemmed Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines
title_short Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines
title_sort synthesis and characterization of chitosan based nanodelivery systems to enhance the anticancer effect of sorafenib drug in hepatocellular carcinoma and colorectal adenocarcinoma cell lines
work_keys_str_mv AT rumanumme synthesisandcharacterizationofchitosanbasednanodeliverysystemstoenhancetheanticancereffectofsorafenibdruginhepatocellularcarcinomaandcolorectaladenocarcinomacelllines
AT buskarankalaivani synthesisandcharacterizationofchitosanbasednanodeliverysystemstoenhancetheanticancereffectofsorafenibdruginhepatocellularcarcinomaandcolorectaladenocarcinomacelllines
AT pastoringiorgia synthesisandcharacterizationofchitosanbasednanodeliverysystemstoenhancetheanticancereffectofsorafenibdruginhepatocellularcarcinomaandcolorectaladenocarcinomacelllines
AT masarudinmasjaffri synthesisandcharacterizationofchitosanbasednanodeliverysystemstoenhancetheanticancereffectofsorafenibdruginhepatocellularcarcinomaandcolorectaladenocarcinomacelllines
AT fakurazisharida synthesisandcharacterizationofchitosanbasednanodeliverysystemstoenhancetheanticancereffectofsorafenibdruginhepatocellularcarcinomaandcolorectaladenocarcinomacelllines
AT husseinmohdzobir synthesisandcharacterizationofchitosanbasednanodeliverysystemstoenhancetheanticancereffectofsorafenibdruginhepatocellularcarcinomaandcolorectaladenocarcinomacelllines